Biotech

All Articles

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Call it a case of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning science, is a...

Praxis epilepsy medicine decreases confiscations in period 2 trial

.Praxis Accuracy Medicines has actually racked up another midphase succeed in epilepsy this year, wi...

Three execs resign as Dyne articles combined records for DMD applicant

.After escaping a clinical hold a number of years back, Dyne Therapy has revealed brand-new stage 1/...

Arrowhead fires off phase 3 records in uncommon metabolic ailment in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its own give in advance of a possible face-off with Ionis, ...

Pfizer, Valneva show lyme health condition shot successful for 2nd enhancer

.Pfizer and also Valneva may have about pair of more years to wait just before they create the 1st c...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Permit's study a discussion with Ayla Ellison, Tough Biotech Editor-in-Chief and Michelle Benz as t...

New data show how Bayer's asundexian fell short to avoid movements

.Bayer put on hold the period 3 trial for its factor XIa prevention asundexian behind time in 2015 a...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is still set on taking its various sclerosis (MS) med tolebrutinib to the FDA, managers have...

Galapagos' stockpile as fund reveals intent to shape its own progression

.Galapagos is actually happening under extra pressure from financiers. Having actually built a 9.9% ...

Cell- concentrated Sana gathers initial CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and...